Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction

Rogelio Zamilpa, Elizabeth F. Lopez, Ying Ann Chiao, Qiuxia Dai, Gladys P. Escobar, Kevin Hakala, Susan T. Weintraub, Merry L. Lindsey

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Matrix metalloproteinase-9 (MMP-9) deletion has been shown to improve remodeling of the left ventricle post-myocardial infarction (MI), but the mechanisms to explain this improvement have not been fully elucidated. MMP-9 has a broad range of in vitro substrates, but relevant in vivo substrates are incompletely defined. Accordingly, we evaluated the infarct regions of wild-type (wt) and MMP-9 null (null) mice using a proteomic strategy. Wt and null groups showed similar infarct sizes (48±3 in wt and 45±3% in null), indicating that both groups received an equal injury stimulus. Left ventricle infarct tissue was homogenized and analyzed by 2-DE and MS. Of 31 spot intensity differences, the intensities of 9 spots were higher and 22 spots were lower in null mice compared to wt (all p<0.05). Several extracellular matrix proteins were identified in these spots by MS, including fibronectin, tenascin-C, thrombospondin-1, and laminin. Fibronectin was observed on the gels at a lower than expected molecular weight in the wt group, which suggested substrate cleavage, and the lower molecular weight spot was observed at lower intensity in the MMP-9 null group, which suggested cleavage by MMP-9. Immunoblotting confirmed the presence of fibronectin cleavage products in the wt samples and lower levels in the absence of MMP-9. In conclusion, examining infarct tissue from wt and MMP-9 null mice by proteomic analysis provides a powerful and unique method to identify in vivo candidate MMP substrates.

Original languageEnglish (US)
Pages (from-to)2214-2223
Number of pages10
JournalProteomics
Volume10
Issue number11
DOIs
StatePublished - Jun 1 2010

Fingerprint

Matrix Metalloproteinase 9
Proteomics
Heart Ventricles
Myocardial Infarction
Substrates
Fibronectins
Molecular Weight
Molecular weight
Tissue
Thrombospondin 1
Tenascin
Ventricular Remodeling
Extracellular Matrix Proteins
Laminin
Matrix Metalloproteinases
Immunoblotting
Gels
Wounds and Injuries

Keywords

  • Animal proteomics
  • Cardiac remodeling
  • Extracellular matrix
  • MMP-9
  • Mice
  • Myocardial infarction

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction. / Zamilpa, Rogelio; Lopez, Elizabeth F.; Chiao, Ying Ann; Dai, Qiuxia; Escobar, Gladys P.; Hakala, Kevin; Weintraub, Susan T.; Lindsey, Merry L.

In: Proteomics, Vol. 10, No. 11, 01.06.2010, p. 2214-2223.

Research output: Contribution to journalArticle

Zamilpa, Rogelio ; Lopez, Elizabeth F. ; Chiao, Ying Ann ; Dai, Qiuxia ; Escobar, Gladys P. ; Hakala, Kevin ; Weintraub, Susan T. ; Lindsey, Merry L. / Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction. In: Proteomics. 2010 ; Vol. 10, No. 11. pp. 2214-2223.
@article{6b1122a9eb114032aba25a2cd7b87f83,
title = "Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction",
abstract = "Matrix metalloproteinase-9 (MMP-9) deletion has been shown to improve remodeling of the left ventricle post-myocardial infarction (MI), but the mechanisms to explain this improvement have not been fully elucidated. MMP-9 has a broad range of in vitro substrates, but relevant in vivo substrates are incompletely defined. Accordingly, we evaluated the infarct regions of wild-type (wt) and MMP-9 null (null) mice using a proteomic strategy. Wt and null groups showed similar infarct sizes (48±3 in wt and 45±3{\%} in null), indicating that both groups received an equal injury stimulus. Left ventricle infarct tissue was homogenized and analyzed by 2-DE and MS. Of 31 spot intensity differences, the intensities of 9 spots were higher and 22 spots were lower in null mice compared to wt (all p<0.05). Several extracellular matrix proteins were identified in these spots by MS, including fibronectin, tenascin-C, thrombospondin-1, and laminin. Fibronectin was observed on the gels at a lower than expected molecular weight in the wt group, which suggested substrate cleavage, and the lower molecular weight spot was observed at lower intensity in the MMP-9 null group, which suggested cleavage by MMP-9. Immunoblotting confirmed the presence of fibronectin cleavage products in the wt samples and lower levels in the absence of MMP-9. In conclusion, examining infarct tissue from wt and MMP-9 null mice by proteomic analysis provides a powerful and unique method to identify in vivo candidate MMP substrates.",
keywords = "Animal proteomics, Cardiac remodeling, Extracellular matrix, MMP-9, Mice, Myocardial infarction",
author = "Rogelio Zamilpa and Lopez, {Elizabeth F.} and Chiao, {Ying Ann} and Qiuxia Dai and Escobar, {Gladys P.} and Kevin Hakala and Weintraub, {Susan T.} and Lindsey, {Merry L.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1002/pmic.200900587",
language = "English (US)",
volume = "10",
pages = "2214--2223",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "11",

}

TY - JOUR

T1 - Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction

AU - Zamilpa, Rogelio

AU - Lopez, Elizabeth F.

AU - Chiao, Ying Ann

AU - Dai, Qiuxia

AU - Escobar, Gladys P.

AU - Hakala, Kevin

AU - Weintraub, Susan T.

AU - Lindsey, Merry L.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Matrix metalloproteinase-9 (MMP-9) deletion has been shown to improve remodeling of the left ventricle post-myocardial infarction (MI), but the mechanisms to explain this improvement have not been fully elucidated. MMP-9 has a broad range of in vitro substrates, but relevant in vivo substrates are incompletely defined. Accordingly, we evaluated the infarct regions of wild-type (wt) and MMP-9 null (null) mice using a proteomic strategy. Wt and null groups showed similar infarct sizes (48±3 in wt and 45±3% in null), indicating that both groups received an equal injury stimulus. Left ventricle infarct tissue was homogenized and analyzed by 2-DE and MS. Of 31 spot intensity differences, the intensities of 9 spots were higher and 22 spots were lower in null mice compared to wt (all p<0.05). Several extracellular matrix proteins were identified in these spots by MS, including fibronectin, tenascin-C, thrombospondin-1, and laminin. Fibronectin was observed on the gels at a lower than expected molecular weight in the wt group, which suggested substrate cleavage, and the lower molecular weight spot was observed at lower intensity in the MMP-9 null group, which suggested cleavage by MMP-9. Immunoblotting confirmed the presence of fibronectin cleavage products in the wt samples and lower levels in the absence of MMP-9. In conclusion, examining infarct tissue from wt and MMP-9 null mice by proteomic analysis provides a powerful and unique method to identify in vivo candidate MMP substrates.

AB - Matrix metalloproteinase-9 (MMP-9) deletion has been shown to improve remodeling of the left ventricle post-myocardial infarction (MI), but the mechanisms to explain this improvement have not been fully elucidated. MMP-9 has a broad range of in vitro substrates, but relevant in vivo substrates are incompletely defined. Accordingly, we evaluated the infarct regions of wild-type (wt) and MMP-9 null (null) mice using a proteomic strategy. Wt and null groups showed similar infarct sizes (48±3 in wt and 45±3% in null), indicating that both groups received an equal injury stimulus. Left ventricle infarct tissue was homogenized and analyzed by 2-DE and MS. Of 31 spot intensity differences, the intensities of 9 spots were higher and 22 spots were lower in null mice compared to wt (all p<0.05). Several extracellular matrix proteins were identified in these spots by MS, including fibronectin, tenascin-C, thrombospondin-1, and laminin. Fibronectin was observed on the gels at a lower than expected molecular weight in the wt group, which suggested substrate cleavage, and the lower molecular weight spot was observed at lower intensity in the MMP-9 null group, which suggested cleavage by MMP-9. Immunoblotting confirmed the presence of fibronectin cleavage products in the wt samples and lower levels in the absence of MMP-9. In conclusion, examining infarct tissue from wt and MMP-9 null mice by proteomic analysis provides a powerful and unique method to identify in vivo candidate MMP substrates.

KW - Animal proteomics

KW - Cardiac remodeling

KW - Extracellular matrix

KW - MMP-9

KW - Mice

KW - Myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=77952990826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952990826&partnerID=8YFLogxK

U2 - 10.1002/pmic.200900587

DO - 10.1002/pmic.200900587

M3 - Article

C2 - 20354994

AN - SCOPUS:77952990826

VL - 10

SP - 2214

EP - 2223

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 11

ER -